Reneo Pharmaceuticals SG&A Expense (Annual) Trends

Reneo Pharmaceuticals Inc (RPHM)

1.51 -0.04 (-2.58%) USD | NASDAQ | Jul 02, 16:00

1.51 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	26.44M
December 31, 2022	16.14M
December 31, 2021	11.65M

Date	Value
December 31, 2020	3.608M
December 31, 2019	2.376M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

2.376M

Minimum

2019

26.44M

Maximum

2023

12.04M

Average

11.65M

Median

2021

SG&A Expense (Annual) Benchmarks